Results 231 to 240 of about 68,932 (288)
Some of the next articles are maybe not open access.
Gonadotropin-releasing hormone agonists
Postgraduate Medicine, 1994Use of gonadotropin-releasing hormone (GnRH) agonists produces a transient increase and subsequent long-term reduction in concentrations of pituitary hormones, resulting in gonadal hormone suppression. This reversible suppression is useful in treating diseases dependent on these hormones.
openaire +2 more sources
Gonadotropin-Releasing Hormone: Agonists and Antagonists
1997In adult women the cyclic function of the ovaries is embedded in the hypothalamic, pituitary, and ovarian feedback mechanisms [1]. The hypothalamus is the superordinate organ releasing gonadotropin-releasing hormone (GnRH) in a pulsatile manner. GnRH is secreted by the neural cells of the nucleus arcuatus in the mediobasal portion of the hypothalamus ...
R. Felberbaum, T. Rabe, K. Diedrich
openaire +1 more source
Gonadotropin releasing hormone agonist treatment before hysteroscopic endometrial resection
International Journal of Gynecology & Obstetrics, 1994AbstractOBJECTIVES: To evaluate the effects of treatment with the gonadotropin releasing hormone (GnRH) agonist goserelin before endometrial resection on absorption of distension medium fluid and technical feasibility of the surgical procedure. METHODS: Fifty‐five patients reporting menorrhagia underwent endometrial resection after 2 months of ...
P. Vercellini +5 more
openaire +2 more sources
Gonadotropin releasing hormone agonists and hormone replacement theory
Reproductive Medicine Review, 1996It has been clearly demonstrated that GnRHa is a powerful suppressant of ovarian steroidogenesis and, as a result, provides alternative strategies in dealing with certain gynaecological disorders. A concern for the deleterious effects of oestrogen deprivation is underscored by the potential long-term application of these compounds.
openaire +1 more source
Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone Agonists
Endocrine Reviews, 1986It is now well established that chronic treatment with GnRH agonists offers an advantageous alternative to orchiectomy and estrogens for the treatment of prostate cancer. Castration levels of androgens can thus be easily achieved without side effects other than those related to castration levels of serum androgens.
F, Labrie +7 more
openaire +2 more sources
Gonadotropin-releasing hormone agonist testing of pituitary-gonadal function
Trends in Endocrinology & Metabolism, 1991The development of gonadotropin-releasing hormone (GnRH) agonists has provided a unique means to functionally assess the pituitary-gonadal axis in both males and females. These agonists, when given in a dose sufficient to stimulate the gonadotropes and induce a gonadal steroid response, have provided insights into normal reproductive physiology ...
D A, Ehrmann, R L, Rosenfield
openaire +2 more sources
INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENT
The Lancet, 1979The stimulatory luteinising hormone-releasing hormone (LRH) analogue D-Ser(TBU)6-EA10-LRH was administered intranasally once daily to twenty-seven regularly menstruating women to determine its efficacy as a contraceptive agent. Ovulation was inhibited during all but 2 of the 89 treatment months.
C, Bergquist, S J, Nillius, L, Wide
openaire +2 more sources
Testicular histology following chronic gonadotropin-releasing hormone agonist treatment
Fertility and Sterility, 1984The histologic appearance of the testes of men exposed to chronic gonadotropin-releasing hormone agonist (GnRH-A) therapy has not been previously documented. Herein, we report on the histologic features of the testes of four patients with disseminated prostatic carcinoma who received at least 1 year of daily treatment with (D-Leu6, des-Gly-NH2(10 ...
J, Rajfer, R S, Swerdloff, D M, Heber
openaire +2 more sources
Gonadotropin Releasing Hormone Agonist Treatment for Central Precocious Puberty
Hormone Research in Paediatrics, 1999Several methodological problems complicate the evaluation of final statural height (FH) benefit after treatment with gonadotropin releasing hormone (GnRH) agonists for central precocious puberty (CPP). Since no controlled study has been performed, we have to rely on indirect methods, comparison with predicted height or with historical controls.
J C, Carel, J L, Chaussain
openaire +2 more sources
American Journal of Obstetrics and Gynecology, 1990
Effects of danazol, gonadotropin-releasing hormone agonist (leuprolide), and danazol-leuprolide combination on experimental endometriosis were evaluated in female rats. A complete resorption of the fluid and a marked decrease in the volume of endometrium autotransplanted under the renal capsule were found after castration (1.4 +/- 0.1 mm3 in castrated,
M, Sakata +6 more
openaire +2 more sources
Effects of danazol, gonadotropin-releasing hormone agonist (leuprolide), and danazol-leuprolide combination on experimental endometriosis were evaluated in female rats. A complete resorption of the fluid and a marked decrease in the volume of endometrium autotransplanted under the renal capsule were found after castration (1.4 +/- 0.1 mm3 in castrated,
M, Sakata +6 more
openaire +2 more sources